Artigos com autorizações de acesso público - Giuseppe Biondi-ZoccaiSaiba mais
20 artigos não disponíveis publicamente
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University …
A Abbate, BW Van Tassell, G Biondi-Zoccai, MC Kontos, JD Grizzard, ...
The American journal of cardiology 111 (10), 1394-1400, 2013
Autorizações: US National Institutes of Health
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)
A Abbate, MC Kontos, NA Abouzaki, RD Melchior, C Thomas, ...
The American journal of cardiology 115 (3), 288-292, 2015
Autorizações: US National Institutes of Health
A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction
MJ Lipinski, RO Escarcega, F D'Ascenzo, MA Magalhaes, NC Baker, ...
The American journal of cardiology 113 (9), 1581-1591, 2014
Autorizações: Government of Spain
Heart failure with preserved ejection fraction: refocusing on diastole
A Abbate, R Arena, N Abouzaki, BW Van Tassell, J Canada, K Shah, ...
International journal of cardiology 179, 430-440, 2015
Autorizações: US National Institutes of Health
Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events
A Abbate, BW Van Tassell, GGL Biondi-Zoccai
BioDrugs 26, 217-233, 2012
Autorizações: US National Institutes of Health
High-intensity interval training in patients with type 2 diabetes mellitus: a systematic review
DE da Silva, AJ Grande, L Roever, G Tse, T Liu, G Biondi-Zoccai, ...
Current atherosclerosis reports 21, 1-10, 2019
Autorizações: UK Medical Research Council
Effects of prolastin C (plasma-derived alpha-1 antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1 …
A Abbate, BW Van Tassell, S Christopher, NA Abouzaki, C Sonnino, ...
The American journal of cardiology 115 (1), 8-12, 2015
Autorizações: US National Institutes of Health
Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials
U Benedetto, M Gaudino, C Ng, G Biondi-Zoccai, F D'Ascenzo, G Frati, ...
International journal of cardiology 210, 19-24, 2016
Autorizações: British Heart Foundation, National Institute for Health Research, UK
A multilevel approach to network meta-analysis within a frequentist framework
T Greco, V Edefonti, G Biondi-Zoccai, A Decarli, M Gasparini, A Zangrillo, ...
Contemporary Clinical Trials 42, 51-59, 2015
Autorizações: Government of Italy
Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE‐CARDIOGROUP IV and USZ …
M Iannaccone, F d'Ascenzo, AH Frangieh, G Niccoli, F Ugo, G Boccuzzi, ...
Catheterization and Cardiovascular Interventions 90 (2), E46-E52, 2017
Autorizações: Swiss National Science Foundation
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design
G Monti, C Galbiati, F Toffoletto, MG Calabrò, S Colombo, B Ferrara, ...
Contemporary clinical trials 104, 106346, 2021
Autorizações: Government of Italy
Intravenous amino acid therapy for kidney protection in cardiac surgery a protocol for a multi-centre randomized blinded placebo controlled clinical trial. The PROTECTION trial
G Landoni, C Brambillasca, MB Redaelli, N Bradić, LK Ti, Z Povšić-Čevra, ...
Contemporary clinical trials 121, 106898, 2022
Autorizações: Government of Italy
Exploring the promise and challenges of artificial intelligence in biomedical research and clinical practice
R Altara, CJ Basson, G Biondi-Zoccai, GW Booz
Journal of cardiovascular pharmacology, 10.1097, 2022
Autorizações: US National Institutes of Health
Last nail in the coffin for propensity scores in observational cardiovascular studies?
G Biondi-Zoccai, AGM Marullo, M Peruzzi, T Palmerini, L Schirone, ...
Journal of the American College of Cardiology 69 (20), 2575-2576, 2017
Autorizações: National Institute for Health Research, UK
Empagliflozin: primum inter pares among sodium-glucose cotransporter-2 inhibitors?
G Biondi-Zoccai, G Frati, M Peruzzi, GW Booz
Journal of Cardiovascular Pharmacology, 10.1097, 2022
Autorizações: US National Institutes of Health, Government of Italy
Finerenone Proves Beneficial for Heart Failure With Preserved Ejection Fraction
G Biondi-Zoccai, M Galli, GW Booz
Journal of Cardiovascular Pharmacology, 10.1097, 2022
Autorizações: US National Institutes of Health, National Institute for Health Research, UK …
T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort
D Pastori, R Carnevale, R Stanzione, C Nocella, M Cotugno, S Marchitti, ...
International Journal of Cardiology 322, 245-249, 2021
Autorizações: Government of Italy
Cardiac Immunotherapy, Immuno-Cardiology and the Future of Cardiovascular Pharmacology
G Biondi-Zoccai, BN Weber, A Abbate, GW Booz
Journal of Cardiovascular Pharmacology, 10.1097, 2022
Autorizações: US National Institutes of Health, American Heart Association, Government of …
Patient reported outcome measures in cardiovascular research and care: PRO (M) s and CONS
G Biondi-Zoccai, G Frati, M Peruzzi, M Bernardi, L Spadafora, E Tremoli
Journal of Cardiovascular Pharmacology, 10.1097, 2022
Autorizações: Government of Italy
Molecular insights on ischemic heart failure: from core genes to hearts
A Buonpane, G Biondi-Zoccai, F Versaci
Journal of Cardiovascular Pharmacology, 10.1097, 2022
Autorizações: Government of Italy
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador